PlumX Metrics
Embed PlumX Metrics

Quantification of Treatment Effect of Tislelizumab vs Sorafenib for Hepatocellular Carcinoma - In Reply

JAMA Oncology, ISSN: 2374-2445, Vol: 10, Issue: 5, Page: 674-675
2024
  • 0
    Citations
  • 0
    Usage
  • 1
    Captures
  • 0
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Letter Description

JAMA Oncology

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know